144 related articles for article (PubMed ID: 23546761)
1. Labeled stem cells as disease models and in drug discovery.
Ellerström C; Strehl R; Hyllner J
Methods Mol Biol; 2013; 997():239-51. PubMed ID: 23546761
[TBL] [Abstract][Full Text] [Related]
2. Human pluripotent stem cells for genetic disease modeling and drug screening.
Gauthier M; Maury Y; Peschanski M; Martinat C
Regen Med; 2011 Sep; 6(5):607-22. PubMed ID: 21916596
[TBL] [Abstract][Full Text] [Related]
3. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
4. Human pluripotent stem cells for disease modelling and drug screening.
Maury Y; Gauthier M; Peschanski M; Martinat C
Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
[TBL] [Abstract][Full Text] [Related]
5. Stem cell models for drug discovery and toxicology studies.
Liu W; Deng Y; Liu Y; Gong W; Deng W
J Biochem Mol Toxicol; 2013 Jan; 27(1):17-27. PubMed ID: 23293059
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
Steel D; Hyllner J; Sartipy P
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
[TBL] [Abstract][Full Text] [Related]
7. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
Irion S; Nostro MC; Kattman SJ; Keller GM
Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
[TBL] [Abstract][Full Text] [Related]
8. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
Crook JM; Kobayashi NR
J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent human stem cells: A novel tool in drug discovery.
Phillips BW; Crook JM
BioDrugs; 2010 Apr; 24(2):99-108. PubMed ID: 20199125
[TBL] [Abstract][Full Text] [Related]
10. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
McGivern JV; Ebert AD
Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
12. Current applications of human pluripotent stem cells: possibilities and challenges.
Ho PJ; Yen ML; Yet SF; Yen BL
Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
[TBL] [Abstract][Full Text] [Related]
13. Progress and prospects: gene transfer into embryonic stem cells.
Yates F; Daley GQ
Gene Ther; 2006 Oct; 13(20):1431-9. PubMed ID: 17016468
[TBL] [Abstract][Full Text] [Related]
14. Concise review: human pluripotent stem cells in the treatment of spinal cord injury.
Lukovic D; Moreno Manzano V; Stojkovic M; Bhattacharya SS; Erceg S
Stem Cells; 2012 Sep; 30(9):1787-92. PubMed ID: 22736576
[TBL] [Abstract][Full Text] [Related]
15. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
16. Differences between human embryonic stem cell lines.
Allegrucci C; Young LE
Hum Reprod Update; 2007; 13(2):103-20. PubMed ID: 16936306
[TBL] [Abstract][Full Text] [Related]
17. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
Puri MC; Nagy A
Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
[TBL] [Abstract][Full Text] [Related]
18. Regulation of 'stemness' and stem cell differentiation by microRNAs.
Sartipy P; Olsson B; Hyllner J; Synnergren J
IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
Song M; Paul S; Lim H; Dayem AA; Cho SG
Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
[TBL] [Abstract][Full Text] [Related]
20. Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.
Garcia-Leon JA; Vitorica J; Gutierrez A
Future Med Chem; 2019 Jun; 11(11):1305-1322. PubMed ID: 31161803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
